United States Carboplatin Market Report & Forecast 2021-2027

Publisher Name :
Date: 05-Oct-2021
No. of pages: 94
Inquire Before Buying

United States Carboplatin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)

United States Carboplatin Market Segment Percentages, By Type, 2020 (%)

- Carboplatin Crystal

- Carboplatin Powder

United States Carboplatin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)

United States Carboplatin Market Segment Percentages, By Application, 2020 (%)

- Carboplatin Injection

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Carboplatin revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Carboplatin revenues share in United States market, 2020 (%)

Key companies Carboplatin sales in United States market, 2016-2021 (Estimated), (K MT)

Key companies Carboplatin sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Teva

- Fresenius Kabi

- Mylan

- Qilu

- Taj Pharmaceuticals

- Tecoland Corporation

- Johnson Matthey

- Heraeus Deutschland

United States Carboplatin Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Carboplatin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Carboplatin Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Carboplatin Overall Market Size
2.1 United States Carboplatin Market Size: 2021 VS 2027
2.2 United States Carboplatin Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Carboplatin Sales: 2016-2027
3 Company Landscape
3.1 Top Carboplatin Players in United States Market
3.2 Top United States Carboplatin Companies Ranked by Revenue
3.3 United States Carboplatin Revenue by Companies
3.4 United States Carboplatin Sales by Companies
3.5 United States Carboplatin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Carboplatin Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Carboplatin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Carboplatin Players in United States Market
3.8.1 List of Tier 1 Carboplatin Companies in United States
3.8.2 List of Tier 2 and Tier 3 Carboplatin Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Carboplatin Market Size Markets, 2021 & 2027
4.1.2 Carboplatin Crystal
4.1.3 Carboplatin Powder
4.2 By Type - United States Carboplatin Revenue & Forecasts
4.2.1 By Type - United States Carboplatin Revenue, 2016-2021
4.2.2 By Type - United States Carboplatin Revenue, 2022-2027
4.2.3 By Type - United States Carboplatin Revenue Market Share, 2016-2027
4.3 By Type - United States Carboplatin Sales & Forecasts
4.3.1 By Type - United States Carboplatin Sales, 2016-2021
4.3.2 By Type - United States Carboplatin Sales, 2022-2027
4.3.3 By Type - United States Carboplatin Sales Market Share, 2016-2027
4.4 By Type - United States Carboplatin Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Carboplatin Market Size, 2021 & 2027
5.1.2 Carboplatin Injection
5.1.3 Others
5.2 By Application - United States Carboplatin Revenue & Forecasts
5.2.1 By Application - United States Carboplatin Revenue, 2016-2021
5.2.2 By Application - United States Carboplatin Revenue, 2022-2027
5.2.3 By Application - United States Carboplatin Revenue Market Share, 2016-2027
5.3 By Application - United States Carboplatin Sales & Forecasts
5.3.1 By Application - United States Carboplatin Sales, 2016-2021
5.3.2 By Application - United States Carboplatin Sales, 2022-2027
5.3.3 By Application - United States Carboplatin Sales Market Share, 2016-2027
5.4 By Application - United States Carboplatin Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Overview
6.1.3 Teva Carboplatin Sales and Revenue in United States Market (2016-2021)
6.1.4 Teva Carboplatin Product Description
6.1.5 Teva Recent Developments
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Corporation Information
6.2.2 Fresenius Kabi Overview
6.2.3 Fresenius Kabi Carboplatin Sales and Revenue in United States Market (2016-2021)
6.2.4 Fresenius Kabi Carboplatin Product Description
6.2.5 Fresenius Kabi Recent Developments
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Overview
6.3.3 Mylan Carboplatin Sales and Revenue in United States Market (2016-2021)
6.3.4 Mylan Carboplatin Product Description
6.3.5 Mylan Recent Developments
6.4 Qilu
6.4.1 Qilu Corporation Information
6.4.2 Qilu Overview
6.4.3 Qilu Carboplatin Sales and Revenue in United States Market (2016-2021)
6.4.4 Qilu Carboplatin Product Description
6.4.5 Qilu Recent Developments
6.5 Taj Pharmaceuticals
6.5.1 Taj Pharmaceuticals Corporation Information
6.5.2 Taj Pharmaceuticals Overview
6.5.3 Taj Pharmaceuticals Carboplatin Sales and Revenue in United States Market (2016-2021)
6.5.4 Taj Pharmaceuticals Carboplatin Product Description
6.5.5 Taj Pharmaceuticals Recent Developments
6.6 Tecoland Corporation
6.6.1 Tecoland Corporation Corporation Information
6.6.2 Tecoland Corporation Overview
6.6.3 Tecoland Corporation Carboplatin Sales and Revenue in United States Market (2016-2021)
6.6.4 Tecoland Corporation Carboplatin Product Description
6.6.5 Tecoland Corporation Recent Developments
6.7 Johnson Matthey
6.7.1 Johnson Matthey Corporation Information
6.7.2 Johnson Matthey Overview
6.7.3 Johnson Matthey Carboplatin Sales and Revenue in United States Market (2016-2021)
6.7.4 Johnson Matthey Carboplatin Product Description
6.7.5 Johnson Matthey Recent Developments
6.8 Heraeus Deutschland
6.8.1 Heraeus Deutschland Corporation Information
6.8.2 Heraeus Deutschland Overview
6.8.3 Heraeus Deutschland Carboplatin Sales and Revenue in United States Market (2016-2021)
6.8.4 Heraeus Deutschland Carboplatin Product Description
6.8.5 Heraeus Deutschland Recent Developments
7 United States Carboplatin Production Capacity, Analysis
7.1 United States Carboplatin Production Capacity, 2016-2027
7.2 Carboplatin Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Carboplatin Supply Chain Analysis
9.1 Carboplatin Industry Value Chain
9.2 Carboplatin Upstream Market
9.3 Carboplatin Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Carboplatin Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Carboplatin in United States Market
Table 2. Top Carboplatin Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Carboplatin Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Carboplatin Revenue Share by Companies, 2016-2021
Table 5. United States Carboplatin Sales by Companies, (K MT), 2016-2021
Table 6. United States Carboplatin Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Carboplatin Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Carboplatin Product Type
Table 9. List of Tier 1 Carboplatin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Carboplatin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Carboplatin Crystal
Table 12. Major Manufacturers of Carboplatin Powder
Table 13. By Type - United States Carboplatin Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Carboplatin Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Carboplatin Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Carboplatin Sales (K MT), 2016-2021
Table 17. By Type - United States Carboplatin Sales (K MT), 2022-2027
Table 18. By Application - United States Carboplatin Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Carboplatin Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Carboplatin Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Carboplatin Sales (K MT), 2016-2021
Table 22. By Application - United States Carboplatin Sales (K MT), 2022-2027
Table 23. Teva Corporation Information
Table 24. Teva Description and Major Businesses
Table 25. Teva Carboplatin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. Teva Carboplatin Product
Table 27. Teva Recent Developments
Table 28. Fresenius Kabi Corporation Information
Table 29. Fresenius Kabi Description and Major Businesses
Table 30. Fresenius Kabi Carboplatin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Fresenius Kabi Carboplatin Product
Table 32. Fresenius Kabi Recent Developments
Table 33. Mylan Corporation Information
Table 34. Mylan Description and Major Businesses
Table 35. Mylan Carboplatin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Mylan Carboplatin Product
Table 37. Mylan Recent Developments
Table 38. Qilu Corporation Information
Table 39. Qilu Description and Major Businesses
Table 40. Qilu Carboplatin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. Qilu Carboplatin Product
Table 42. Qilu Recent Developments
Table 43. Taj Pharmaceuticals Corporation Information
Table 44. Taj Pharmaceuticals Description and Major Businesses
Table 45. Taj Pharmaceuticals Carboplatin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. Taj Pharmaceuticals Carboplatin Product
Table 47. Taj Pharmaceuticals Recent Developments
Table 48. Tecoland Corporation Corporation Information
Table 49. Tecoland Corporation Description and Major Businesses
Table 50. Tecoland Corporation Carboplatin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. Tecoland Corporation Carboplatin Product
Table 52. Tecoland Corporation Recent Developments
Table 53. Johnson Matthey Corporation Information
Table 54. Johnson Matthey Description and Major Businesses
Table 55. Johnson Matthey Carboplatin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. Johnson Matthey Carboplatin Product
Table 57. Johnson Matthey Recent Developments
Table 58. Heraeus Deutschland Corporation Information
Table 59. Heraeus Deutschland Description and Major Businesses
Table 60. Heraeus Deutschland Carboplatin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 61. Heraeus Deutschland Carboplatin Product
Table 62. Heraeus Deutschland Recent Developments
Table 63. Carboplatin Production Capacity (K MT) of Key Manufacturers in United States Market, 2019-2021 (K MT)
Table 64. United States Carboplatin Capacity Market Share of Key Manufacturers, 2019-2021
Table 65. Carboplatin Market Opportunities & Trends in United States Market
Table 66. Carboplatin Market Drivers in United States Market
Table 67. Carboplatin Market Restraints in United States Market
Table 68. Carboplatin Raw Materials
Table 69. Carboplatin Raw Materials Suppliers in United States Market
Table 70. Typical Carboplatin Downstream
Table 71. Carboplatin Downstream Clients in United States Market
Table 72. Carboplatin Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Carboplatin Product Picture
Figure 2. Carboplatin Segment by Type
Figure 3. Carboplatin Segment by Application
Figure 4. United States Carboplatin Market Overview: 2020
Figure 5. United States Carboplatin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Carboplatin Revenue, 2016-2027 (US$, Mn)
Figure 7. Carboplatin Sales in United States Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Carboplatin Revenue in 2020
Figure 9. Carboplatin Crystal Product Picture
Figure 10. Carboplatin Powder Product Picture
Figure 11. By Type - United States Carboplatin Sales Market Share, 2016-2027
Figure 12. By Type - United States Carboplatin Revenue Market Share, 2016-2027
Figure 13. By Type - United States Carboplatin Price (USD/MT), 2016-2027
Figure 14. Carboplatin Injection
Figure 15. Others
Figure 16. By Application - United States Carboplatin Sales Market Share, 2016-2027
Figure 17. By Application - United States Carboplatin Revenue Market Share, 2016-2027
Figure 18. By Application - United States Carboplatin Price (USD/MT), 2016-2027
Figure 19. Teva Carboplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Fresenius Kabi Carboplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Mylan Carboplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Qilu Carboplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Taj Pharmaceuticals Carboplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Tecoland Corporation Carboplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Johnson Matthey Carboplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Heraeus Deutschland Carboplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United States Carboplatin Production Capacity (K MT), 2016-2027
Figure 28. Carboplatin Industry Value Chain
Figure 29. Marketing Channels
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs